4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancersquamous cell carcinoma of penisNot yet recruitingPhase 22026-09-11NCT07815197
Sac-TMT in Vaginal and Vulvar Cancersvaginal squamous cell carcinoma, vulvar squamous cell carcinomaNot yet recruitingPhase 22026-09-04NCT07804966
Epidemiological Profile of Patients With IDH-Mutant Diffuse Gliomas Diagnosed From 2021 in BrazilDiffuse Glioma; IDH-mutant GliomasNot yet recruitingNot stated2026-09-04NCT07789678
A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)Brain Metastases, Neoplasms by Site, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung cancer, lung disorder, lung neoplasm, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22026-08-26NCT06822543